Ads
related to: treatment for carcinoid tumors injection molding- Access & Savings
See How You Can Access This TGCT
Treatment for Eligible Patients.
- View Safety Info
TGCT Treatment Safety Information
for Healthcare Providers.
- Identify Patients
Get Information on How to Identify
Patients for this TGCT Treatment.
- GCT-TS Education
Learn More About Tenosynovial Giant
Cell Tumor. Get Information Here.
- Find a TGCT Center
Ready to Start Treatment? Find a
Treatment Center Here.
- TGCT Treatment Option
Discover a Prescription Treatment
For Eligible Patients with TGCT.
- Access & Savings
Search results
Results From The WOW.Com Content Network
Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly.
It was previously used in the treatment of breast cancer, but has been replaced by more effective and less toxic agents. Estrace is an estrogen which was also formerly used for antiandrogen therapy of prostate cancer. [2] Polyestradiol phosphate is a long-acting derivative of estradiol that is applied as an intramuscular injection.
[2] [3] His work has shed light on the molecular characteristics of neuroendocrine tumors and has led to the development of multiple new treatments for this condition. [4] [5] His research studies led to the development and approval of telotristat ethyl, a tryptophan hydroxylase inhibitor, [6] for the treatment of patients with carcinoid ...
The Neuroendocrine Tumor Research Foundation (NETRF), previously known as the Caring for Carcinoid Foundation (CFCF), is a nonprofit corporation organized under the laws of Massachusetts in order to support neuroendocrine and carcinoid cancer research in the public interest. The mission of NETRF is to fund research to discover cures and more ...
Carcinoid tumors are the most common malignant tumor of the appendix, but they are most commonly associated with the small intestine, and they can also be found in the rectum and stomach. They are known to grow in the liver, but this finding is usually a manifestation of metastatic disease from a primary carcinoid occurring elsewhere in the body.
Treatments have improved over the past several decades, and outcomes are improving. [49] In malignant carcinoid tumors with carcinoid syndrome, the median survival has improved from two years to more than eight years. [75] Detailed guidelines for managing neuroendocrine tumors are available from ESMO, [76] NCCN [77] and a UK panel. [1]
Ads
related to: treatment for carcinoid tumors injection molding